ArticleBMC microbiology2012
Allelic sequence heterozygosity in single Giardia parasites.
Article in BMC microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 58 citations in OpenAlex.
- Molecular characterization and zoonotic potential ofFood and waterborne parasitology · 2026Article
- High resolution multi-locus sequence typing scheme for Giardia duodenalis assemblage B outbreak and population analysis.PLoS neglected tropical diseases · 2026Article
- Host range expansion of asexual parasite can be explained by loss of adaptions in Muller's Ratchet.Nature communications · 2025Article
- Variation in haplotypes in single cysts of assemblages C and D, but not of assemblage E of Giardia duodenalis.BMC microbiology · 2022Article
- Efficient CRISPR/Cas9-mediated gene disruption in the tetraploid protistOpen biology · 2022Article
- Neglected Diseases-Parasitic Infections among Slovakian Children from Different Populations and Genotypes ofMicroorganisms · 2022Article
- A hybrid sequencing and assembly strategy for generating culture freeCurrent research in microbial sciences · 2022Article
- Multilocus sequence typing ofFrontiers in medicine · 2022Article
- Zoonotic giardiasis: an update.Parasitology research · 2021Review
- Occurrence of Giardia duodenalis in selected stations and tributary rivers of Laguna Lake, Philippines.Environmental monitoring and assessment · 2021Article
- Detection of enteric parasites and molecular characterization ofParasitology · 2021Article
- Suitability of current typing procedures to identify epidemiologically linked human Giardia duodenalis isolates.PLoS neglected tropical diseases · 2021Article
- Multilocus Genotyping ofPathogens (Basel, Switzerland) · 2021Article
- Molecular diversity of Giardia duodenalis in children under 5 years from the Manhiça district, Southern Mozambique enrolled in a matched case-control study on the aetiology of diarrhoea.PLoS neglected tropical diseases · 2021Article
- The controversies surroundingCurrent research in parasitology & vector-borne diseases · 2021Review
- Molecular Characterization ofMicroorganisms · 2020Article
- Genetic Diversity of the Flavohemoprotein Gene ofInfection and drug resistance · 2020Article
- Multilocus genotyping of Giardia duodenalis in Southwestern Iran. A community survey.PloS one · 2020Article
- Clone-based haplotyping of Giardia intestinalis assemblage B human isolates.Parasitology research · 2019Article
- Molecular epidemiology of Giardia duodenalis infection in humans in Southern Ethiopia: a triosephosphate isomerase gene-targeted analysis.Infectious diseases of poverty · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGenetic heterogeneity has become a major inconvenience in the genotyping and molecular epidemiology of the intestinal protozoan parasite Giardia intestinalis, in particular for the major human infecting genotype, assemblage B. Sequence-based genotyping of assemblage B Giardia from patient fecal samples, where one or several of the commonly used genotyping loci (beta-giardin, triosephosphate isomerase and glutamate dehydrogenase) are implemented, is often hampered due to the presence of sequence heterogeneity in the sequencing chromatograms. This can be due to allelic sequence heterozygosity (ASH) and /or co-infections with parasites of different assemblage B sub-genotypes. Thus, two important questions have arisen; i) does ASH occur at the single cell level, and/or ii) do multiple sub-genotype infections commonly occur in patients infected with assemblage B, G. intestinalis isolates?
resultsWe used micromanipulation in order to isolate single Giardia intestinalis, assemblage B trophozoites (GS isolate) and cysts from human patients. Molecular analysis at the tpi loci of trophozoites from the GS lineage indicated that ASH is present at the single cell level. Analyses of assemblage B Giardia cysts from clinical samples at the bg and tpi loci also indicated ASH at the single cell level. Additionally, alignment of sequence data from several different cysts that originated from the same patient yielded different sequence patterns, thus suggesting the presence of multiple sub-assemblage infections in congruence with ASH within the same patient.
conclusionsOur results conclusively show that ASH does occur at the single cell level in assemblage B Giardia. Furthermore, sequence heterogeneity generated during sequence-based genotyping of assemblage B isolates may possess the complexity of single cell ASH in concurrence with co-infections of different assemblage B sub-genotypes. These findings explain the high abundance of sequence heterogeneity commonly found when performing sequence based genotyping of assemblage B Giardia, and illuminates the necessity of developing new G. intestinalis genotyping tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.